Overexpression of adenylate cyclase-associated protein 1 may predict brain metastasis in non-small cell lung cancer

Oncology Reports

Volumn 33, Issue 1, 2015, Pages 363-371

  Xie, Shuan Shuan ^a   Tan, Min ^a   Lin, Hai Yan ^a   Xu, Lei ^a   Shen, Chang Xing ^a   Yuan, Qing ^a   Song, Xiao Lian ^a   Wang, Chang Hui ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Biomarker; Brain metastasis; Lung cancer

Indexed keywords

ADENYLATE CYCLASE; ADENYLATE CYCLASE ASSOCIATED PROTEIN 1; UNCLASSIFIED DRUG; CAP1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYTOSKELETON PROTEIN; TUMOR MARKER;

AGED; AREA UNDER THE CURVE; ARTICLE; BRAIN METASTASIS; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VISCERAL METASTASIS; WESTERN BLOTTING; BRAIN TUMOR; CASE CONTROL STUDY; FOLLOW UP; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; REGRESSION ANALYSIS; SECONDARY; SURVIVAL;

AGED; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CYTOSKELETAL PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; REGRESSION ANALYSIS; ROC CURVE; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84916233709     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3577     Document Type: Article

References (21)

1. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
2. Walling J: Chemotherapy for advanced non-small-cell lung cancer. Respir Med 88: 649-657, 1994.
3. Govindan R, Page N, Morgensztern D, et al: Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 24: 4539-4544, 2006.
4. Strauss GM, Herndon JE, Sherman DD, et al: Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 10: 1237-1244, 1992.
5. Albain KS, Rusch VW, Crowley JJ, et al: Concurrent cisplatin/ etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13: 1880-1892, 1995.
6. Andre F, Grunenwald D, Pujol JL, et al: Patterns of relapse of N2 non-small-cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered? Cancer 91: 2394-2400, 2001.
7. Carmichael J, Crane JM, Bunn PA, et al: Results of therapeutic cranial irradiation in small cell lung cancer. Int J Radiat Oncol Biol Phys 14: 455-459, 1998.
8. Cox JD, Stanley K, Petrovich Z, et al: Cranial irradiation in cancer of the lung of all cell types. JAMA 245: 469-472, 1981.
9. Arriagada R, Le Chevalier T, Borie F, et al: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 87: 183-190, 1995.
10. Shaw EG, Su JQ, Eagan RT, et al: Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases. J Clin Oncol 12: 2327-2332, 1994.
11. Langer CJ and Mehta MP: Current management of brain metastases, with a focus on systemic options. J Clin Oncol 23: 6207-6219, 2005.
12. Tan M, Song X, Zhang G, et al: Overexpression of adenylate cyclase-associated protein 1 is associated with metastasis of lung cancer. Oncol Rep 30: 1639-1644, 2013.
13. Delattre JY, Krol G, Thaler HT and Posner JB: Distribution of brain metastases. Arch Neurol 45: 741-744, 1988.
14. Fedor-Chaiken M, Deschenes RJ and Broach JR: SRV2, a gene required for RAS activation of adenylate cyclase in yeast. Cell 61: 329-340, 1990.
15. Field J, Vojtek A, Ballester R, et al: Cloning and characterization of CAP, the S. cerevisiae gene encoding the 70 kd adenylyl cyclase-associated protein. Cell 61: 319-327, 1990.
16. Matviw H, Yu G and Young D: Identification of a human cDNA encoding a protein that is structurally and functionally related to the yeast adenylyl cyclase-associated CAP proteins. Mol Cell Biol 12: 5033-5040, 1992.
17. Freeman NL, Chen Z, Horenstein J, Weber A and Field J: An actin monomer binding activity localizes to the carboxyl-terminal half of the Saccharomyces cerevisiae cyclase-associated protein. J Biol Chem 270: 5680-5685, 1995.
18. Moriyama K and Yahara I: Human CAP1 is a key factor in the recycling of cofilin and actin for rapid actin turnover. J Cell Sci 115: 1591-1601, 2002.
19. Hubberstey AV and Mottillo EP: Cyclase-associated proteins: CAPacity for linking signal transduction and actin polymerization. FASEB J 16: 487-499, 2002.
20. Loisel TP, Boujemaa R, Pantaloni D and Carlier MF: Reconstitution of actin-based motility of Listeria and Shigella using pure proteins. Nature 401: 613-616, 1999.
21. Yamazaki K, Takamura M, Masugi Y, et al: Adenylate cyclaseassociated protein 1 overexpressed in pancreatic cancers is involved in cancer cell motility. Lab Invest 89: 425-432, 2009.